期刊文献+

基于环状RNA靶点探讨中医药治疗结直肠癌的分子互作与干预策略

Exploring Molecular Interactions and Intervention Strategies of Traditional Chinese Medicine for Colorectal Cancer Based on circRNA Targets
原文传递
导出
摘要 结直肠癌作为全球高发的恶性肿瘤,其病理进程涉及复杂的分子调控网络。环状RNA(circRNA)作为新型非编码RNA分子,通过miRNA海绵、蛋白互作及翻译功能参与结直肠癌的发生发展,为肿瘤治疗提供了新的靶点。该文系统解析了circRNA在结直肠癌中的生物合成、功能特性及失调机制,重点综述中医药调控circRNA治疗结直肠癌的研究进展;探讨中药复方、单味中药及中药单体成分通过调控circRNA网络干预结直肠癌的分子互作模式,提出“中药成分-circRNA-靶蛋白”三维互作模型;指出结合单细胞测序与化学生物探针技术解析动态调控网络的研究方向。该研究为开发基于circRNA靶点的中医药精准治疗方案提供了理论依据,有助于推动传统医学与现代分子靶向治疗的深度融合。 Colorectal cancer,a highly prevalent malignant tumor worldwide,involves complex molecular regulatory networks in its pathological progression.Circular RNAs(circRNA),as novel non-coding RNA molecules,participate in the pathogenesis and progression of colorectal cancer through miRNA sponging,protein interactions,and translational functions,thereby providing new targets for cancer therapy.This article systematically elucidates the biogenesis,functional characteristics,and dysregulation mechanisms of circRNAs in colorectal cancer,with a focused review on the research advances in traditional Chinese medicine(TCM)regulating circRNA for colorectal cancer treatment.It explores the molecular interaction patterns by which TCM compounds,single herbs,and active components intervene in colorectal cancer through the regulation of circRNA networks,and proposes a threedimensional interaction model of“TCM component-circRNA-target protein”.The review also highlights future research directions integrating single-cell sequencing and chemical biology probes to decipher dynamic regulatory networks.This work provides a theoretical basis for developing precision TCM therapeutic strategies targeting circRNA,contributing to the deep integration of traditional medicine and modern molecular targeted therapies.
作者 曹鑫越 李许诺 张名山 王祎韵 高铭凰 王奇 喻良文 刘金满 CAO Xinyue;LI Xunuo;ZHANG Mingshan;WANG Yiyun;GAO Minghuang;WANG Qi;YU Liangwen;LIU Jinman(Science and Technology Innovation Center,Guangzhou University of Chinese Medicine,Guangzhou 510405 Guangdong,China;Guangzhou University of Chinese Medicine,Guangzhou 510006 Guangdong,China;Central Laboratory,Affiliated Jiangmen TCM Hospital of Jinan University,Jiangmen 529099 Guangdong,China)
出处 《中药新药与临床药理》 北大核心 2025年第12期2202-2210,共9页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 国家自然科学基金青年科学基金项目(82405230)。
关键词 结直肠癌 环状RNA 中医药治疗 分子互作 靶向干预 研究进展 colorectal cancer circular RNA traditional Chinese medicine therapy molecular interactions targeted intervention research progress
  • 相关文献

参考文献13

二级参考文献84

  • 1潘勇,周慧俊,李威,向左娟,陈珊珊,曾媚姿,刘世坤.miR-124-3p表达水平与结直肠癌的关系及其逆转耐奥沙利铂HCT116细胞耐药性研究[J].中国临床药理学杂志,2020,36(4):419-423. 被引量:4
  • 2蒋益兰,潘敏求,蔡美.健脾消癌饮配合化疗拮抗大肠癌术后复发转移62例总结[J].湖南中医杂志,2007,23(1):1-3. 被引量:55
  • 3Chekhonin V P,Shein S A,Korchagina A A,et al.VEGF in tumor progression and targeted therapy [J].Curr Cancer Drug Targets,2013,13(4):423-443.
  • 4Pare-Brunet L,Glubb D,Evans P,et al.Discovery and functional assessment of gene variants in the vascular endothelial growth factor pathway [J].Hum Mutat,2014,35(2):227-235.
  • 5Chung,S,Dwabe S,Elshimali Y,et al.Identification of novel biomarkers for metastatic colorectal cancer using angiogenesis-antibody array and intracellular signaling array [J].PLoS One,2015,10(8):e0134948.
  • 6Alahuhta I,Aikio M,Vayrynen O,et al.Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment [J].Exp Cell Res,2015,336(1):130-140.
  • 7蒋益兰,罗星,李勇敏,等.健脾消癌方对裸鼠大肠癌肝转移模型VEGF以及VEGFR-2表达的影响[A]//第十四届全国中西医结合肿瘤学术大会论文集[C].长沙:湖南中医药大学,2014.
  • 8Cespedes M V,Espina C,Garcia-Cabezas M A,et al.Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites [J].Am J Pathol,2007,170(3):1077-1085.
  • 9Pommier AJ,Farren M,Patel B,et al.Leptin,BMI,and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer [J].Cell Metab,2016,23(1):77-93.
  • 10Poluzzi C,Iozzo R V,Schaefer L.Endostatin and endorepellin,a common route of action for similar angiostatic cancer avengers [J].Adv Drug Deliv Rev,2016,97:156-173.

共引文献2325

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部